. 2019 Dec 18;3(2):e9815. doi: 10.2196/cardio.9815

Table 4.

Rate of reviewed transmissions, benchmarking phase versus external remote monitoring center phase.

Device type	Benchmarking phase			Monitoring center phase			P value
Device type	Total exposure time (years)	Reviewed TX^a, n	Annual rate of hospital physician reviewed TX per 100 patient-years (95% CI)	Total exposure time (years)	Reviewed TX, n	Annual rate of hospital physician reviewed TX per 100 patient-years (95% CI)
Overall (patients, n=126)	105	368	350 (316-387)	89	78^b	88 (69-109)	<.001
CRT-D^c (n=55)	41	214	527 (461-603)	39	42	108 (78-146)	<.001
ICD^d (n=12)	10	35	366 (263-509)	8	6	75 (28-163)	<.001
IPG^e (n=58)	54	115	213 (177-255)	41	5	12 (4-28)	<.001
CRT-P^f (n=1)	1	4	411 (154-1096)	1	0	—^g	—

^aTX: transmissions.

^b10 (14.7%) were classified as red.

^cCRT-D: cardiac resynchronization therapy defibrillator.

^dICD: single- or dual-chamber implantable cardioverter defibrillator.

^eIPG: single- or dual-chamber pacemaker.

^fCRT-P: cardiac resynchronization therapy pacemaker.

^gNot applicable.